Table 3.
|
Naloxone Prescribing |
X-Waiver Receipt |
X-Waiver Interest |
||||||
---|---|---|---|---|---|---|---|---|---|
Variable | OR | SE | 95% CI | OR | SE | 95% CI | OR | SE | 95% CI |
Age | 1.00 | .01 | .97, 1.02 | 1.01 | .01 | .99, 1.04 | 1.02 | .02 | .98, 1.05 |
Weekly work hours | 1.02 | .01 | 1.00, 1.04 | 1.01 | .01 | .99, 1.03 | 1.00 | .02 | .97, 1.03 |
Sex | .34*** | .31 | .18, .62 | .60 | .27 | .35, 1.02 | .35** | .39 | .16, .76 |
FQHC | 1.24 | .31 | .68, 2.27 | 1.55 | .28 | .90, 2.67 | .65 | .45 | .27, 1.57 |
Locale | 1.47 | .21 | .98, 2.21 | .91 | .18 | .64, 1.30 | 1.28 | .25 | .78, 2.10 |
Appalachian | .73 | .41 | .33, 1.62 | 1.31 | .38 | .62, 2.75 | .63 | .59 | .20, 1.99 |
Tenure | 1.03 | .02 | .98, 1.07 | 1.03 | .02 | .99, 1.07 | .98 | .03 | .92, 1.04 |
Race | 1.82 | .54 | .63, 5.23 | 1.09 | .43 | .47, 2.52 | .65 | .69 | .17, 2.53 |
Explicit bias | .63 | .24 | .39, 1.01 | .64 | .23 | .40, 1.00 | 1.02 | .31 | .56, 1.86 |
General contact | 1.03** | .01 | 1.01, 1.04 | 1.03*** | .01 | 1.02, 1.04 | 1.02 | .01 | .99, 1.05 |
Positive contact | 1.37* | .14 | 1.04, 1.82 | 1.96*** | .14 | 1.49, 2.57 | 2.09*** | .21 | 1.38, 3.17 |
Empathy | 1.04 | .17 | .74, 1.47 | 1.03 | .16 | .74, 1.42 | 1.52 | .23 | .96, 2.39 |
Pseudo R 2 | .259 | .348 | .249 |
Note: N = 400; sex is coded 1 = male, 2 = female; FQHC = federally qualified health center and is coded 0 = no, 1 = yes; locale is coded 1 = urban, 2 = suburban, 3 = rural; Appalachian is coded 0 = no, 1 = yes; race is coded 0 = white, 1 = minority;
p < .05
p < .01
p < .001.